AILERON THERAPEUTICS INC (ALRN) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	27.6	26.6	20.5	12.3	13.5	8.8	7.9	5.1
General and administrative				12.3	13.5	8.8	7.9	5.1
Research and development				17.7	18.4	14.2	10.3	7.8
EBITDA [+]	-27.5	-26.5	-20.3	-29.8	-31.7	-22.9	-17.9	-12.6
EBITDA growth	3.8%	30.3%	-31.8%	-5.9%	38.5%	27.6%	42.7%
Depreciation and amortization	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.3
EBIT [+]	-27.6	-26.6	-20.5	-30.0	-31.9	-23.0	-18.2	-12.9
EBIT growth	3.9%	29.8%	-31.6%	-6.1%	38.7%	26.6%	40.9%
Interest income					0.4	0.4	0.0	0.0
Interest income					0.4	0.4	0.0	0.0
Other income (expense), net	0.3	0.4	-0.7	0.6
Pre-tax income	-27.3	-26.2	-21.2	-29.4	-31.5	-22.6	-18.1	-12.9
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-27.3	-26.2	-21.2	-29.4	-31.5	-22.6	-18.2	-12.9

Basic EPS [+]	($6.02)	($5.89)	($0.61)	($1.20)	($2.14)	($3.04)	($42.35)	($32.31)
Growth	2.2%	871.1%	-49.3%	-44.1%	-29.6%	-92.8%	31.1%
Diluted EPS [+]	($6.02)	($5.89)	($0.61)	($1.20)	($2.14)	($3.04)	($42.35)	($32.31)
Growth	2.2%	871.1%	-49.3%	-44.1%	-29.6%	-92.8%	31.1%

Shares outstanding (basic) [+]	4.5	4.4	34.9	24.5	14.7	7.4	0.4	0.4
Growth	2.2%	-87.3%	42.1%	66.5%	98.0%	1632.2%	7.2%
Shares outstanding (diluted) [+]	4.5	4.4	34.9	24.5	14.7	7.4	0.4	0.4
Growth	2.2%	-87.3%	42.1%	66.5%	98.0%	1632.2%	7.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.